WFDC2 and ovarian carcinoma: We also observed that CTC detection results (positive rates) did not exactly match HE4 IHC results in ovarian cancer patients; some HE4 IHC positive patients had negative CTCs, while some HE4 IHC negative patients had positive CTCs.